SFX by Ex Libris Inc.

Title:	The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53
Source:	Cell [0092-8674] Pomerantz, Jason yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Liao, S. "A survey of market orientation research (1995–2008)." Industrial marketing management 40.2 (2010): 301-310.
description	2.	Serrano, M. "Role of the INK4a locus in tumor suppression and cell mortality." Cell 85.1: 27-37.
description	3.	Luo, R.X. X. "Rb interacts with histone deacetylase to repress transcription." Cell 92.4 (1998): 463-473.
description	4.	Palmero, I. "p19(ARF) links the tumour suppressor p53 to Ras." Nature 395.6698 (1998): 125-126.
description	5.	Pestell, R. "The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation." Endocrine reviews 20.4 (1999): 501-534.
description	6.	Raju, Subhash S. "Market orientation in the context of SMEs: A conceptual framework." Journal of business research 64.12 (2011): 1320-1326.
description	7.	Laukkanen, T. "Does market orientation pay off without brand orientation? A study of small business entrepreneurs." Journal of marketing management 32.7-8 (2015): 1-22.
description	8.	Mellahi, K. "Market Orientation, Corporate Social Responsibility, and Business Performance." Journal of business ethics 99.3 (2011): 307-324.
description	9.	Dibb, P. "Further Thoughts on the Marketing Trifid: The Case of Marketing Orientation." Journal of marketing education 22.3 (2000): 214-224.
description	10.	Jean, Jean J. "The role of a firm's strategic orientation dimensions in determining market orientation." Industrial marketing management 41.4 (2011): 715-724.
description	11.	Magnaghi-Jaulin, L.. "Retinoblastoma protein represses transcription by recruiting a histone deacetylase." Nature 391.6667 (1998): 601-605.
description	12.	Chin, L. "Essential role for oncogenic Ras in tumour maintenance." Nature 400.6743: 468-472.
description	13.	Joëls, M. "Stress and the brain: from adaptation to disease." Nature reviews. Neuroscience 6.6 (2005): 463-75.
description	14.	Drummond, G. "Introduction to Marketing Concepts." Introduction to marketing concepts /. Elsevier/Butterworth Heinemann, 2005.
description	15.	Shankland, S J. "Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis." American journal of physiology. Renal physiology 278.4 (2000): -29.
description	16.	Rowland, Benjamin D D. "E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest." Cancer cell 2.1 (2002): 55-65.
description	17.	DOWDY, S. "PHYSICAL INTERACTION OF THE RETINOBLASTOMA PROTEIN WITH HUMAN D-CYCLINS." Cell 73.3 (1993): 499-511.
description	18.	Harbour, J W W. "Chromatin remodeling and Rb activity." Current opinion in cell biology 12.6 (2000): 685-689.
description	19.	de Stanchina, E. "E1A signaling to p53 involves the p19(ARF) tumor suppressor." Genes & development 12.15 (1998): 2434-2442.
description	20.	Huot, Thomas J. "Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts." Molecular and cellular biology 22.23 (2002): 8135-8143.